NVO
Novo Nordisk A/SStock · Health Care$45.97+$1.44 (+3.23%)as of market close, Aug 6, 2026
NVO — Novo Nordisk A/S stock price, chart and key statistics
Key stats
Price data
- Price
- $45.97
- Change YTD
- -9.65%
- Market cap
- 204.5B
- Enterprise value
- 219.4B
- Shares outstanding
- 4.4B
- 52W low
- $35.12
- 52W high
- $64.16
- From 52W high
- -28.35%
- From 52W low
- +30.89%
- 52W range
- 37%
- Beta
- 0.74
Volume
- Rel volume
- 0.99×
- 30D volume
- 12M
- 30D $ vol
- 575.6M
Fundamentals
- Sales (ttm)
- 46.6B
- Sales/share
- $10.49
- EPS (ttm)
- $3.48
- FCF (ttm)
- 18B
- FCF/share
- $4.04
- Book value/share
- $6.87
- Net margin
- 33.14%
- ROE
- 50.62%
- ROA
- 18.09%
- Debt / equity
- 0.57×
- Current ratio
- 0.80
Growth (CAGR, ttm) · 10Y
- Sales
- n/a
- Net income
- n/a
- Shares
- n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- n/a
- Book value/share
- n/a
- Dividend/share
- n/a
- Price
- +6.31%
- Total return
- +8.59%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 13.2×
- Fwd P/E
- 13.4×
- P/S (ttm)
- 4.4×
- P/B (mrq)
- 6.7×
- P/FCF (ttm)
- 11.4×
- EV/EBITDA (fy)
- 10.2×
- EV/Sales (ttm)
- 4.7×
- FCF yield (ttm)
- 8.79%
- Dividend yield (fwd)
- 3.84%
- Dividend/share (fwd)
- $1.77
- Buyback yield (realized, 1y)
- 0.34%
- Shareholder yield (realized, 1y)
- 4.16%
- Buyback yield (cash, ttm)
- 0.10%
- Shareholder yield (cash, ttm)
- 3.92%
Performance · price return
1D
+3.23%
1W
-10.93%
1M
-5.97%
3M
+0.46%
YTD
-9.65%
1Y
-2.65%
5Y
+0.62%
Financial statements
Open full NVO financials →Related Health Care
1MNovo Nordisk A/S (NVO) trades at $45.97 with a live price and an interactive chart covering 45+ years of daily price history, plus key valuation metrics. ChartRow also publishes NVO's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full NVO financial statements →
